Clinical Trial Comparing TaurolockTMHep100 (Taurolidine 1.35%) and 0.9% Saline As Prevention of Recurrent Catheter-related Bloodstream Infections

Clinical trial NCT06660641 · COMPLETED

Trial details

NCT number: NCT06660641
Sponsor: Rigshospitalet, Denmark
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Catheter Related Blood Stream Infections Intestinal Failure

Start date: 2019-06-03
Primary completion: 2022-02-28
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.